OMB Home White House Website

Agency:    Department of Defense--Military
Bureau:    Research, Development, Test, and Evaluation
Account:    Research, development, test, and evaluation, Army (21-2040)
Certifying Official:    Deputy Comptroller Program/Budget
Contact Information:    http://WWW.DOD.GOV   703-697-5131
Blood Safety & Decontamination Technology

1 recipient will receive $4,600,000. This is a continuing earmark.
Year Enacted: 2005
Description: Cerus Corporation is developing technology to inactivate a broad spectrum of pathogens and leukocytes in the three major blood components: platelets,plasma, and red blood cells. This project focuses on advanced development of the pathogen inactivation (PI) technology in red blood cells (RBC) for introduction into military and civilian practice. The approaches described are used to address specific problems applicable to the US civilian and Armed Forces` blood supply.
Beneficiary/Recipient Amount ($K) Program Type Address
Cerus Corporation $4,600 For-Profit
Concord, CA
Source: Appropriations Report Language - Conference
Reference: 108-622
Location: Line 31, Page 257
Citation Excerpt: Blood Safety & Decontamination Technology

Last Modified: 16-Apr-2007

Federal Register    |   Jobs at OMB   |   FOIA   |  OMB Locator   |   |   Accessibility   |   Privacy Policy   |   Site Search   |   Help